Cargando…
The optimal timing of FDG-PET/CT in non-small cell lung cancer diagnosis and staging in an Australian centre
BACKGROUND: Clinical practice guidelines and re-imbursement schedules vary in the recommended timing of FDG-PET/CT in the diagnostic evaluation of suspected or confirmed lung cancer. The aim was to estimate the probability of requiring more than one invasive test to complete diagnosis and staging in...
Autores principales: | Johnson, Anne, Norman, Richard, Piccolo, Francesco, Manners, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252249/ https://www.ncbi.nlm.nih.gov/pubmed/34210303 http://dx.doi.org/10.1186/s12890-021-01564-w |
Ejemplares similares
-
FDG PET/CT in the Staging of Lung Cancer
por: Farsad, Mohsen
Publicado: (2020) -
Prostatic Adenocarcinoma Masquerading as Generalized lymphadenopathy and Mimicking lymphoma on FDG PET/CT: Diagnosis, Staging, and Evaluation of Therapy Response by FDG PET/CT
por: Joshi, Prathamesh, et al.
Publicado: (2012) -
FDG PET and CT radiomics in diagnosis and prognosis of non-small-cell lung cancer
por: Hannequin, Pascal, et al.
Publicado: (2022) -
The utility of (18)F-FDG PET and PET/CT in the diagnosis and staging of chondrosarcoma: a meta-analysis
por: Zhang, Qingyu, et al.
Publicado: (2020) -
The Utility of Metabolic Imaging by 18F-FDG PET/CT in Lung Cancer: Impact on Diagnosis and Staging
por: Yousefi-Koma, Abbas, et al.
Publicado: (2013)